https://www.selleckchem.com/Bcl-2.html
Background - Current expert consensus recommends remote monitoring (RM) for cardiac implantable electronic devices, with at least annual in-office follow-up. We studied safety and resource consumption of exclusive remote follow-up (RFU) in pacemaker patients for two years. Methods - In Japan, consecutive pacemaker patients committed to RM were randomized to either RFU or conventional in-office follow-up (CFU) at twice-yearly intervals. RFU patients were only seen if indicated by remote monitoring. All returned to hospital after two years. The prim
Like
Comment
Share
